J Musculoskelet Neuronal Interact., 2011; 11(1): 34-45, PMID: 21364273
Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass
Felsenberg D, Bock O, Börst H, Armbrecht G, Beller G, Degner C, Stephan-Oelkers M, Schacht E, Mazor Z, Hashimoto J, Roth HJ, Martus P, Runge M
Center of Muscle and Bone Research, Charité - University Medicine Berlin, Campus Benjamin Franklin, Free University and Humboldt University Berlin, Berlin, Germany.
Abstract
Objectives: Assessment of additive impact of alfacalcidol 1Product groups: pQCT Bone Density & Bone Geometry
Topics: Clinical Studies, Clinical Application, Osteoporosis, Neuronal Diseases, Disease Patterns, Medical Faculties, Physiotherapy & Rehabilitation, Diagnostics with Leonardo & pQCT, Basics, Therapy & Prevention with Galileo®, Stroke, Back Pain, Geriatrics
Doc-ID: 2587,
More information: Original Article
